CD38 and acute myeloid leukemia: The ALDHlow cells had aberrant marker expression (frequency corresponds with that of marker expression on leukemic CD45dim blasts of the corresponding AML, median is 25% marker expression on CD34+CD38– ALDHlow cells, Table 1) and a higher FSC/SSC, suggesting to be CD34+CD38– LSC.